Bioavailability Study of Fexofenadine HCl New Formulation Tablet
Status:
COMPLETED
Trial end date:
2024-05-23
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the relative bioavailability of a new galenic form of fexofenadine HCl new formulation tablet (test drug) taken with or without water compared to fexofenadine HCl film-coated tablets (reference form) taken with water under fasting conditions.